SPRINGBIG HOLDINGS INC (SBIG)

US85021Q1085 - Common Stock

0.1912  -0.04 (-16.83%)

After market: 0.145 -0.05 (-24.16%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to SBIG. SBIG was compared to 278 industry peers in the Software industry. SBIG may be in some trouble as it scores bad on both profitability and health. SBIG is valied quite expensively at the moment, while it does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year SBIG has reported negative net income.
In the past year SBIG has reported a negative cash flow from operations.

1.2 Ratios

The profitability ratios for SBIG are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

SBIG has a Gross Margin of 77.36%. This is in the better half of the industry: SBIG outperforms 75.72% of its industry peers.
The Profit Margin and Operating Margin are not available for SBIG so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.36%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

SBIG does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SBIG has more shares outstanding
The debt/assets ratio for SBIG is higher compared to a year ago.

2.2 Solvency

SBIG has an Altman-Z score of -7.93. This is a bad value and indicates that SBIG is not financially healthy and even has some risk of bankruptcy.
SBIG's Altman-Z score of -7.93 is on the low side compared to the rest of the industry. SBIG is outperformed by 89.13% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -7.93
ROIC/WACCN/A
WACC10.17%

2.3 Liquidity

SBIG has a Current Ratio of 0.60. This is a bad value and indicates that SBIG is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.60, SBIG is doing worse than 89.49% of the companies in the same industry.
A Quick Ratio of 0.60 indicates that SBIG may have some problems paying its short term obligations.
The Quick ratio of SBIG (0.60) is worse than 89.13% of its industry peers.
Industry RankSector Rank
Current Ratio 0.6
Quick Ratio 0.6

4

3. Growth

3.1 Past

SBIG shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1209.72%.
Looking at the last year, SBIG shows a very strong growth in Revenue. The Revenue has grown by 330.89%.
EPS 1Y (TTM)-1209.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.22%
Revenue 1Y (TTM)330.89%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%12.46%

3.2 Future

Based on estimates for the next years, SBIG will show a very strong growth in Earnings Per Share. The EPS will grow by 26.96% on average per year.
SBIG is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 38.51% yearly.
EPS Next Y69.76%
EPS Next 2Y42.15%
EPS Next 3Y28.75%
EPS Next 5Y26.96%
Revenue Next Year13.11%
Revenue Next 2Y19.24%
Revenue Next 3Y24.6%
Revenue Next 5Y38.51%

3.3 Evolution

3

4. Valuation

4.1 Price/Earnings Ratio

SBIG reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
SBIG is valuated rather expensively with a Price/Forward Earnings ratio of 18.75.
83.70% of the companies in the same industry are more expensive than SBIG, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 22.83. SBIG is around the same levels.
Industry RankSector Rank
PE N/A
Fwd PE 18.75

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as SBIG's earnings are expected to grow with 28.75% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y42.15%
EPS Next 3Y28.75%

0

5. Dividend

5.1 Amount

No dividends for SBIG!.
Industry RankSector Rank
Dividend Yield N/A

SPRINGBIG HOLDINGS INC

NASDAQ:SBIG (9/1/2023, 8:00:02 PM)

After market: 0.145 -0.05 (-24.16%)

0.1912

-0.04 (-16.83%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)08-10 2023-08-10/amc
Earnings (Next)N/A N/A
Inst Owners0.08%
Inst Owner Change0%
Ins Owners19.65%
Ins Owner Change0.37%
Market Cap7.95M
Analysts84.44
Price Target1.43 (647.91%)
Short Float %0%
Short Ratio0.01
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-50.9%
Min EPS beat(2)-56.86%
Max EPS beat(2)-44.93%
EPS beat(4)2
Avg EPS beat(4)-10.17%
Min EPS beat(4)-56.86%
Max EPS beat(4)34.64%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-10.65%
Min Revenue beat(2)-18.08%
Max Revenue beat(2)-3.22%
Revenue beat(4)1
Avg Revenue beat(4)-6.81%
Min Revenue beat(4)-18.08%
Max Revenue beat(4)4.43%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.67%
PT rev (3m)-13.4%
EPS NQ rev (1m)0%
EPS NQ rev (3m)18.51%
EPS NY rev (1m)0%
EPS NY rev (3m)-8.64%
Revenue NQ rev (1m)-1.33%
Revenue NQ rev (3m)-3.9%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.1%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 18.75
P/S 0.29
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.51
EYN/A
EPS(NY)0.01
Fwd EY5.33%
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS0.66
BVpS-0.14
TBVpS-0.14
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.36%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover3.31
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.6
Quick Ratio 0.6
Altman-Z -7.93
F-Score2
WACC10.17%
ROIC/WACCN/A
Cap/Depr(3y)410.48%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.97%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1209.72%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%44.22%
EPS Next Y69.76%
EPS Next 2Y42.15%
EPS Next 3Y28.75%
EPS Next 5Y26.96%
Revenue 1Y (TTM)330.89%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%12.46%
Revenue Next Year13.11%
Revenue Next 2Y19.24%
Revenue Next 3Y24.6%
Revenue Next 5Y38.51%
EBIT growth 1Y-224.79%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year85.33%
EBIT Next 3Y33.01%
EBIT Next 5Y32.04%
FCF growth 1Y-80.33%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-84.15%
OCF growth 3YN/A
OCF growth 5YN/A